Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-02-22 @ 12:23 PM
Study NCT ID:
NCT02349867
Status:
COMPLETED
Last Update Posted:
2022-09-19
First Post:
2015-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer
Sponsor:
Virginia Commonwealth University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Adenocarcinoma | View |
| None | Stage IA Pancreatic Cancer | View |
| None | Stage IB Pancreatic Cancer | View |
| None | Stage IIA Pancreatic Cancer | View |
| None | Stage IIB Pancreatic Cancer | View |
| None | Stage III Pancreatic Cancer | View |
| None | Recurrent Pancreatic Carcinoma | View |
Keywords: